Abiopharma

Clinical trial NCT05633550 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-08-01 3. enrollment: 45 → 50 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05417594 updates: 1. completion date: 2027-11-01 → 2028-02-07 2. primary completion date: 2027-11-01 → 2028-02-07

Clinical trial NCT07226817: enrollment: 140 → 240 participants.

Clinical trial NCT07504601: start date: 2026-08-16 → 2026-08-17.

Clinical trial NCT07324629 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-03-13

Clinical trial NCT07424144 updates: 1. status: ENROLLING_BY_INVITATION → ACTIVE_NOT_RECRUITING 2. completion date: 2028-12-12 → 2027-02-17 3. primary completion date: 2028-12-12 → 2027-02-17 4. enrollment: 380 → 59 participants 5. enrollment type: ESTIMATED → ACTUAL

General Announcement: Receipt of Letter of Financial Support

Extra Space Storage CEO Joe Margolis Named One of Glassdoors Best CEOs of 2026

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Directors Interest - Tan Wei Yang, Melvin

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation